T. E. Hilditch

1.8k citations
53 papers · 1.3k indexed · 1 hit paper · h-index 16

T. E. Hilditch

50 papers receiving 1.2k citations

Hit Papers

Phase I clinical and pharmacokinetic study of PK1 [N-(2-h...5741999202620082017100200300400500

Peers

T. E. Hilditch
Comparison fields: 5 of 111
  • Biomaterials 361
  • Gastroenterology 117
  • Chemical Health and Safety 8
  • Ophthalmology 85
  • Radiology, Nuclear Medicine and Imaging 188
Replace Victoria Doviner with:
Victoria Doviner Israel
Christian Mittermayer Germany
Katsuyuki Kusuzaki Japan
Monica Huszar Israel
Di Yang China
Xiaoli Wei China
Yanling Ma United States
Takao Matsubara Japan
Kangshun Zhu China
Kazuyuki Murase Japan
T. E. Hilditch relative to Victoria Doviner Israel Victoria Doviner's profile →
Citations per field
00.5×6.2×
Victoria Doviner · 1×
Citations per year

Countries citing papers authored by T. E. Hilditch

Since Specialization
Citations

This map shows the geographic impact of T. E. Hilditch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. E. Hilditch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. E. Hilditch more than expected).

Fields of papers citing papers by T. E. Hilditch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. E. Hilditch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. E. Hilditch. The network helps show where T. E. Hilditch may publish in the future.

Co-authorship network

The 25 scholars most cited alongside T. E. Hilditch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with T. E. Hilditch Line = papers co-authored together T. E. Hilditch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20001
2 200018
3 20006
4 200020
5
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.breakdown →
1999574
6 199829
7 19983
8 19964
9 199558
10 1991121
11 19904
12 198822
13 19881
14 198713
15 198717
16 19858
17 198423
18 198325
19 19805
20 197438

About T. E. Hilditch

T. E. Hilditch is a scholar working on Chemical Health and Safety, Radiology, Nuclear Medicine and Imaging and Gastroenterology, having authored 53 papers that have together received 1.3k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (11 papers), Medical Imaging and Pathology Studies (8 papers), Medical Imaging Techniques and Applications (6 papers), Radiation Dose and Imaging (5 papers), Thyroid Disorders and Treatments (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Neuroblastoma Research and Treatments (4 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). The work is most often cited by research in Biomaterials (361 citations), Gastroenterology (117 citations) and Chemical Health and Safety (8 citations). T. E. Hilditch has collaborated with scholars based in United Kingdom, Mexico and South Korea. Frequent co-authors include T. Murray, Lilian S. Murray, J Cassidy, Rachel Morrison, Alison H. Thomson, Ruth Duncan, S S Burtles, Peter D. Wilson, P. Vasey and E. Frigerio. Their work appears in journals such as Nuclear Medicine Communications, European Journal of Nuclear Medicine and Molecular Imaging, The Lancet, Physics in Medicine and Biology and British Journal of Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026